Literature DB >> 16538507

Toll-like receptors 2, 3 and 4 (TLR-2, TLR-3 and TLR-4) are expressed in the microenvironment of human acquired cholesteatoma.

Mirosław Szczepański1, Witold Szyfter, Renata Jenek, Maciej Wróbel, Iwona Mozer Lisewska, Jan Zeromski.   

Abstract

Human toll-like receptors (TLR 1-10) are crucial in the induction and activation of innate immunity in the course of an infection. They are expressed mainly on the cells of the immune system, and also on some epithelia and endothelia. Their ligands so called pathogen associated molecular patterns are abundant on invading microbes. TLR-ligand binding results in cell signal transduction and subsequent production of various proinflammatory cytokines such as IL-1 and TNF-alpha. Acquired cholesteatoma is formed during chronic otitis media in the proportion of cases. It has adverse effects on ear structures, resulting in osteolysis and bone resorption. Its formation and pathogenesis are not fully understood. The current study attempted to search the possible role of TLRs in this somewhat awkward pathological condition. Surgical specimens of human acquired cholesteatoma (n=15) and normal external auditory canal skin (n=5, control tissues) were tested by immunohistochemistry for the presence of TLRs. Three TLRs were examined: TLR-2, TLR-3 and TLR-4. All TLRs tested were demonstrated in matrix (layer of keratinizing epithelium) and perimatrix (granulation tissue) of this inflammatory tumour. Expression of particular TLRs within the keratinizing epithelium was distinct and uneven. In the perimatrix, numerous T (CD3+) cells were seen and relatively few macrophages (CD11c+, HLA-DR+). There was a weak expression of all TLRs on normal (non-inflammatory) skin. Expression of TLR-3 both on the epithelium and some cells within the perimatrix and the presence of T cells may suggest that apart from innate immune responses, mechanisms of adaptive immunity also operate in cholesteatoma. Weak expression of these receptors on normal skin may also suggest the important role of TLRs in the etiopathogenesis of cholesteatoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16538507     DOI: 10.1007/s00405-006-0030-1

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  14 in total

1.  Toll-like receptor signalling pathways as key targets for mediating the anti-inflammatory and immunosuppressive effects of glucocorticoids.

Authors:  P N Moynagh
Journal:  J Endocrinol       Date:  2003-11       Impact factor: 4.286

Review 2.  The Toll-receptor family and control of innate immunity.

Authors:  E B Kopp; R Medzhitov
Journal:  Curr Opin Immunol       Date:  1999-02       Impact factor: 7.486

3.  Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic.

Authors:  J Harder; J Bartels; E Christophers; J M Schroder
Journal:  J Biol Chem       Date:  2000-11-20       Impact factor: 5.157

4.  Lipopolysaccharide concentration and bone resorption in cholesteatoma.

Authors:  F A W Peek; M A Huisman; R J Berckmans; A Sturk; J Van Loon; J J Grote
Journal:  Otol Neurotol       Date:  2003-09       Impact factor: 2.311

5.  Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells.

Authors:  Lisa C Parker; Moira K B Whyte; Stefanie N Vogel; Steven K Dower; Ian Sabroe
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

6.  [Immunomorphological evaluation of cholesteatoma].

Authors:  Jerzy Kuczkowski; Alicja Bakowska; Bogusław Mikaszewski
Journal:  Otolaryngol Pol       Date:  2004

Review 7.  Toll-like receptor 3: a link between toll-like receptor, interferon and viruses.

Authors:  Misako Matsumoto; Kenji Funami; Hiroyuki Oshiumi; Tsukasa Seya
Journal:  Microbiol Immunol       Date:  2004       Impact factor: 1.955

8.  Toll-like receptor-4 is involved in eliciting an LPS-induced oxidative burst in neutrophils.

Authors:  Katharina A Remer; Marija Brcic; Thomas W Jungi
Journal:  Immunol Lett       Date:  2003-01-02       Impact factor: 3.685

9.  Human keratinocytes express functional CD14 and toll-like receptor 4.

Authors:  Peter I Song; Young-Min Park; Tonya Abraham; Brad Harten; Adam Zivony; Natalia Neparidze; Cheryl A Armstrong; John C Ansel
Journal:  J Invest Dermatol       Date:  2002-08       Impact factor: 8.551

10.  A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes.

Authors:  D Bruch-Gerharz; K Fehsel; C Suschek; G Michel; T Ruzicka; V Kolb-Bachofen
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

View more
  13 in total

Review 1.  The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma.

Authors:  Shumin Xie; Xiaoli Wang; Jihao Ren; Wei Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-16       Impact factor: 2.503

2.  Assessment of expression of toll-like receptors 2, 3 and 4 in laryngeal carcinoma.

Authors:  Mirosław Szczepański; Maria Stelmachowska; Lukasz Stryczyński; Wojciech Golusiński; Husam Samara; Iwona Mozer-Lisewska; Jan Zeromski
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-12-13       Impact factor: 2.503

3.  Expression of pattern recognition receptors in cholesteatoma.

Authors:  Ho Yun Lee; Moon Suh Park; Jae Yong Byun; Young Il Kim; Seung Geun Yeo
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-26       Impact factor: 2.503

4.  Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.

Authors:  Miroslaw J Szczepanski; Malgorzata Czystowska; Marta Szajnik; Malgorzata Harasymczuk; Michael Boyiadzis; Aleksandra Kruk-Zagajewska; Witold Szyfter; Jan Zeromski; Theresa L Whiteside
Journal:  Cancer Res       Date:  2009-03-24       Impact factor: 12.701

5.  Moraxella catarrhalis activates murine macrophages through multiple toll like receptors and has reduced clearance in lungs from TLR4 mutant mice.

Authors:  Ferdaus Hassan; Dabin Ren; Wenhong Zhang; Tod J Merkel; Xin-Xing Gu
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

6.  NOD-Like Receptor Signaling in Cholesteatoma.

Authors:  Anke Leichtle; Christin Klenke; Joerg Ebmeyer; Markus Daerr; Karl-Ludwig Bruchhage; Anna Sophie Hoffmann; Allen F Ryan; Barbara Wollenberg; Holger Sudhoff
Journal:  Biomed Res Int       Date:  2015-04-02       Impact factor: 3.411

7.  Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis.

Authors:  Miroslaw J Szczepanski; Michal Luczak; Ewa Olszewska; Marta Molinska-Glura; Mariola Zagor; Antoni Krzeski; Henryk Skarzynski; Jan Misiak; Karolina Dzaman; Mikolaj Bilusiak; Tomasz Kopec; Malgorzata Leszczynska; Henryk Witmanowski; Theresa L Whiteside
Journal:  J Mol Med (Berl)       Date:  2014-11-12       Impact factor: 4.599

Review 8.  TLR-Dependent Human Mucosal Epithelial Cell Responses to Microbial Pathogens.

Authors:  Ryan McClure; Paola Massari
Journal:  Front Immunol       Date:  2014-08-12       Impact factor: 7.561

9.  Large-scale proteomics differentiates cholesteatoma from surrounding tissues and identifies novel proteins related to the pathogenesis.

Authors:  Anders Britze; Rune Isak Dupont Birkler; Niels Gregersen; Therese Ovesen; Johan Palmfeldt
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

Review 10.  Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.

Authors:  Mahmood A Hamed; Seiichi Nakata; Ramadan H Sayed; Hiromi Ueda; Badawy S Badawy; Yoichi Nishimura; Takuro Kojima; Noboru Iwata; Ahmed R Ahmed; Khalid Dahy; Naoki Kondo; Kenji Suzuki
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.